The current median survival time of patients with
acute myelogenous lukemia who achieve complete remission from
conventional treatment is 21 months. A new procedure is being
studied. Researchers hoped that with this new procedure, the median
survival time will be improved. The following is the survival time
for 10 patients who received the new treatment:
Patient: 1,2,3,4,5,6,7,8,9,10
Survival Time: 24.1, 25.8, 20.5, 20.9, 27.3, 21.5, 20.1, 28.9,
19.2, 26.3
A) Let M be the median survival time for patients under the...